Free Trial

AlloVir (ALVR) Short Interest Ratio & Short Volume

AlloVir logo
$9.63 -0.20 (-2.03%)
Closing price 02/21/2025 03:59 PM Eastern
Extended Trading
$9.46 -0.17 (-1.77%)
As of 02/21/2025 06:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AlloVir Short Interest Data

AlloVir (ALVR) has a short interest of 59,500 shares, representing 2.60% of the float (the number of shares available for trading by the public). This marks a -14.02% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.3, indicating that it would take 2.3 days of the average trading volume of 30,726 shares to cover all short positions.

Current Short Interest
59,500 shares
Previous Short Interest
69,200 shares
Change Vs. Previous Month
-14.02%
Dollar Volume Sold Short
$560,490.00
Short Interest Ratio
2.3 Days to Cover
Last Record Date
January 31, 2025
Outstanding Shares
5,042,000 shares
Float Size
2,290,000 shares
Short Percent of Float
2.60%
Today's Trading Volume
5,095 shares
Average Trading Volume
30,726 shares
Today's Volume Vs. Average
17%
Short Selling AlloVir?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for AlloVir and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ALVR Short Interest Over Time

ALVR Days to Cover Over Time

ALVR Percentage of Float Shorted Over Time

AlloVir Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/202559,500 shares $560,490.00 -14.0%2.6%2.3 $9.42
1/15/202569,200 shares $606,558.76 -94.5%3.0%2.8 $8.77
12/31/20241,260,000 shares $529,200.00 -25.4%N/A3.4 $0.42
12/15/20241,690,000 shares $760,500.00 -12.0%N/A4.8 $0.45
11/30/20241,920,000 shares $1.05 million +57.4%N/A6 $0.55
11/15/20241,220,000 shares $694,180.00 -69.1%N/A4.1 $0.57
10/31/20243,950,000 shares $3.67 million -19.2%N/A15.4 $0.93
10/15/20244,890,000 shares $3.83 million -11.1%N/A32.4 $0.78
9/30/20245,500,000 shares $4.45 million -4.5%N/A33.7 $0.81
9/15/20245,760,000 shares $4.33 million +0.7%N/A19.4 $0.75
8/31/20245,720,000 shares $4.46 million +3.1%N/A18.3 $0.78
8/15/20245,550,000 shares $4.05 million -3.0%N/A16.4 $0.73
7/31/20245,720,000 shares $4.24 million +0.9%N/A15.3 $0.74
7/15/20245,670,000 shares $4.48 million -6.3%N/A14.6 $0.79
6/30/20246,050,000 shares $4.38 million -2.4%N/A14.4 $0.72
6/15/20246,200,000 shares $4.72 million +2.5%N/A15.8 $0.76
5/31/20246,050,000 shares $4.57 million -4.7%N/A14.3 $0.75
5/15/20246,350,000 shares $4.76 million -5.5%N/A13.9 $0.75
4/30/20246,720,000 shares $5.34 million +5.0%N/A12.1 $0.79
4/15/20246,400,000 shares $4.78 million +1.6%N/A8.2 $0.75
3/31/20246,300,000 shares $4.76 million +0.5%N/A5.2 $0.75
3/15/20246,270,000 shares $4.88 million +5.7%N/A3.2 $0.78
2/29/20245,930,000 shares $4.37 million +7.4%N/A2.9 $0.74
2/15/20245,520,000 shares $3.81 million +12.2%N/A2.6 $0.69
1/31/20244,920,000 shares $3.54 million +2.5%N/A2.3 $0.72
1/15/20244,800,000 shares $3.34 million -37.7%N/A2.4 $0.70
12/31/20237,700,000 shares $5.23 million -32.0%N/A4.3 $0.68
12/15/202311,320,000 shares $26.83 million -1.0%N/A8.2 $2.37
11/30/202311,430,000 shares $21.49 million -1.5%N/A12.8 $1.88
11/15/202311,600,000 shares $19.49 million +2.4%N/A14.7 $1.68
10/31/202311,330,000 shares $17.00 million +1.8%N/A13.3 $1.50
10/15/202311,130,000 shares $19.14 million -2.5%N/A13.8 $1.72
9/30/202311,420,000 shares $24.55 million +28.3%N/A14.1 $2.15
9/15/20238,900,000 shares $22.34 million +7.1%N/A10.2 $2.51
8/31/20238,310,000 shares $26.01 million +7.6%N/A9.6 $3.13
8/15/20237,720,000 shares $21.15 million +4.0%N/A9.2 $2.74
7/31/20237,420,000 shares $24.41 million +1.5%N/A11.4 $3.29
7/15/20237,310,000 shares $25.59 million +0.4%N/A11.9 $3.50
6/30/20237,280,000 shares $24.75 million -1.1%N/A13.1 $3.40
6/15/20237,360,000 shares $41.00 million +1.0%N/A16.3 $5.57
Buy this AI Stock Before Elon’s Announcement (Ad)

With Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dust. This isn't just a prediction; it's a calculated shift backed by political support, policy changes, and Musk's proven track record. I've identified a company that is quietly enabling xAI's rapid growth.

Click here to watch my presentation and learn how to invest today.
5/31/20237,290,000 shares $27.48 million +3.7%N/A28.8 $3.77
5/15/20237,030,000 shares $30.09 million -2.1%N/A29 $4.28
4/30/20237,180,000 shares $24.70 million +6.9%N/A25.9 $3.44
4/15/20236,720,000 shares $26.07 million +4.0%N/A24.9 $3.88
3/31/20236,460,000 shares $25.45 million +11.6%N/A23.3 $3.94
3/15/20235,790,000 shares $29.12 million +6.8%N/A21 $5.03
2/28/20235,420,000 shares $36.59 million +20.4%N/A21.1 $6.75
2/15/20234,500,000 shares $28.08 million +5.9%N/A17.5 $6.24
1/31/20234,250,000 shares $24.57 million -2.8%N/A17.7 $5.78
1/15/20234,370,000 shares $25.61 million +1.2%N/A16.6 $5.86
12/30/20224,320,000 shares $22.16 million +2.4%N/A15.9 $5.13
12/15/20224,220,000 shares $25.57 million +0.7%N/A14.6 $6.06
11/30/20224,190,000 shares $31.47 million -1.9%N/A13.4 $7.51
11/15/20224,270,000 shares $34.16 million +0.2%N/A12.4 $8.00
10/31/20224,260,000 shares $29.52 million -6.8%N/A11.1 $6.93
10/15/20224,570,000 shares $40.90 million -1.7%N/A8.7 $8.95
9/30/20224,650,000 shares $36.69 million +8.1%N/A9.4 $7.89
9/15/20224,300,000 shares $36.08 million +3.4%N/A9 $8.39
8/31/20224,160,000 shares $31.24 million -19.9%N/A8.6 $7.51
8/15/20225,190,000 shares $44.48 million +3.4%N/A10.4 $8.57
7/31/20225,020,000 shares $23.04 million +5.5%N/A9.9 $4.59
7/15/20224,760,000 shares $23.90 million +0.2%N/A11.5 $5.02
6/30/20224,750,000 shares $18.53 million -3.3%N/A2.6 $3.90
6/15/20224,910,000 shares $17.14 million -8.2%N/A2.7 $3.49
5/31/20225,350,000 shares $20.70 million +3.9%N/A3 $3.87
5/15/20225,150,000 shares $21.84 million -22.1%N/A2.9 $4.24
4/30/20226,610,000 shares $30.08 million +68.6%N/A3.9 $4.55
4/15/20223,920,000 shares $22.19 million -0.3%N/A2.3 $5.66
3/31/20223,930,000 shares $26.53 million -10.3%N/A13.8 $6.75
3/15/20224,380,000 shares $32.54 million -0.7%N/A15.5 $7.43
2/28/20224,410,000 shares $39.69 million +3.5%N/A15.9 $9.00
2/15/20224,260,000 shares $37.79 million +4.9%N/A15.2 $8.87
1/31/20224,060,000 shares $33.13 million +10.0%N/A15.4 $8.16
1/15/20223,690,000 shares $38.38 million +9.5%N/A16.8 $10.40
12/31/20213,370,000 shares $43.61 million +10.1%N/A17.4 $12.94
12/15/20213,060,000 shares $47.46 million +9.7%N/A16.1 $15.51
11/30/20212,790,000 shares $48.71 million -2.1%N/A15 $17.46
11/15/20212,850,000 shares $61.93 million -0.4%N/A14.8 $21.73
10/29/20212,860,000 shares $68.67 million +2.9%N/A14.4 $24.01
10/15/20212,780,000 shares $61.74 million -1.4%N/A13.1 $22.21
9/30/20212,820,000 shares $70.67 million -1.7%N/A12.6 $25.06
9/15/20212,870,000 shares $65.61 million -11.2%N/A12.6 $22.86
8/31/20213,230,000 shares $62.18 million -22.5%N/A13.4 $19.25
8/13/20214,170,000 shares $77.90 million -3.7%N/A17.8 $18.68
7/30/20214,330,000 shares $82.88 million +4.1%N/A18 $19.14
7/15/20214,160,000 shares $71.97 million +1.2%N/A17.7 $17.30
6/30/20214,110,000 shares $81.13 million -4.9%N/A16.6 $19.74
6/15/20214,320,000 shares $90.33 million +0.5%N/A15.2 $20.91
5/28/20214,300,000 shares $100.79 million -2.3%N/A12.2 $23.44
5/14/20214,400,000 shares $98.34 million +0.2%16.1%11.7 $22.35
Buy this AI Stock Before Elon’s Announcement (Ad)

With Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dust. This isn't just a prediction; it's a calculated shift backed by political support, policy changes, and Musk's proven track record. I've identified a company that is quietly enabling xAI's rapid growth.

Click here to watch my presentation and learn how to invest today.
4/30/20214,390,000 shares $106.24 million +5.8%16.1%11.5 $24.20
4/15/20214,150,000 shares $97.77 million +2.5%15.2%10.6 $23.56
3/31/20214,050,000 shares $89.87 million +57.0%14.8%10.8 $22.19
3/15/20212,580,000 shares $77.66 million +32.3%9.5%6.4 $30.10
2/26/20211,950,000 shares $78.39 million -1.0%7.2%6.6 $40.20
2/12/20211,970,000 shares $83.78 million -6.6%7.4%7.4 $42.53
1/29/20212,110,000 shares $79.88 million -33.0%7.9%8.4 $37.86
1/15/20213,150,000 shares $142.51 million No Change11.8%13.7 $45.24

ALVR Short Interest - Frequently Asked Questions

What is AlloVir's current short interest?

Short interest is the volume of AlloVir shares that have been sold short but have not yet been covered or closed out. As of January 31st, traders have sold 59,500 shares of ALVR short. 2.60% of AlloVir's shares are currently sold short. Learn More on AlloVir's current short interest.

What is a good short interest ratio for AlloVir?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ALVR shares currently have a short interest ratio of 2.0. Learn More on AlloVir's short interest ratio.

Which institutional investors are shorting AlloVir?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of AlloVir: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for AlloVir?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.60% of AlloVir's floating shares are currently sold short.

Is AlloVir's short interest increasing or decreasing?

AlloVir saw a decrease in short interest in the month of January. As of January 31st, there was short interest totaling 59,500 shares, a decrease of 14.0% from the previous total of 69,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is AlloVir's float size?

AlloVir currently has issued a total of 5,042,000 shares. Some of AlloVir's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. AlloVir currently has a public float of 2,290,000 shares.

How does AlloVir's short interest compare to its competitors?

2.60% of AlloVir's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to AlloVir: Cybin Inc. (3.51%), Acelyrin, Inc. (8.09%), MediWound Ltd. (11.35%), Invivyd, Inc. (8.81%), Pliant Therapeutics, Inc. (11.88%), Nanobiotix S.A. (0.04%), Inhibrx, Inc. (12.27%), Acrivon Therapeutics, Inc. (5.01%), ProQR Therapeutics (1.13%), Aclaris Therapeutics, Inc. (5.49%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks.

What does it mean to sell short AlloVir stock?

Short selling ALVR is an investing strategy that aims to generate trading profit from AlloVir as its price is falling. ALVR shares are trading down $0.20 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against AlloVir?

A short squeeze for AlloVir occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ALVR, which in turn drives the price of the stock up even further.

How often is AlloVir's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALVR, twice per month. The most recent reporting period available is January, 31 2025.




This page (NASDAQ:ALVR) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners